Elevatus Welath Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.12M Buy
6,455
+2,091
+48% +$653K 0.51% 36
2026
Q2
$1.89M Buy
4,364
+1,512
+53% +$459K 0.46% 52
2026
Q1
$609K Buy
2,852
+158
+6% +$35.3K 0.32% 60
2025
Q4
$461K Buy
2,694
+777
+41% +$121K 0.13% 92
2025
Q3
$257K Buy
+1,917
New +$203K 0.07% 109
2023
Q3
– Sell
-91,220
Closed -$5.86M – 79
2023
Q2
$5.86M Buy
+91,220
New +$5.14M 4.07% 6

Other funds holding LRCX

Elevatus Welath Management's LRCX Position: Q3 2026 in Review

Elevatus Welath Management increased its Lam Research (LRCX) stake by 48% in Q3 2026, buying an estimated $653K and bringing the position to 6,455 shares worth $2.12M. The position accounts for 0.51% of the portfolio, ranked #36.

Elevatus Welath Management first reported a position in LRCX in Q2 2023 and has held it in 6 quarters since. The position peaked at $5.86M in Q2 2023. 2,736 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Elevatus Welath Management held 6,455 shares of Lam Research worth $2.12M as of Q3 2026.
  • Elevatus Welath Management bought 2,091 Lam Research shares in Q3 2026, an estimated $653K.
  • Lam Research made up 0.51% of Elevatus Welath Management's portfolio in Q3 2026, its #36 holding.
  • Elevatus Welath Management first reported a position in Lam Research in Q2 2023 and has held it in 6 quarters since.
  • Elevatus Welath Management's Lam Research position peaked at $5.86M in Q2 2023.
  • 2,736 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Elevatus Welath Management's 13F filing for Q3 2026, filed 19 Oct 2026.